Implantable ultrasound device augments chemo in glioblastoma

Implantable ultrasound device augments chemo in glioblastoma
(HealthDay)—An implantable ultrasound device (SonoCloud) appears to enhance chemotherapy treatment in glioblastoma, according to research published online June 15 in Science Translational Medicine.

Researchers from the Pitie-Salpetriere Hospital in Paris and other French institutions tested the on 15 patients with recurrent glioblastoma. The intention of the device is to disrupt the blood-brain barrier long enough for subsequent chemotherapy to reach the brain.

Frédéric Sottilini, the of Paris-based CarThera, the company developing SonoCloud, explained how the ultrasound device works: It's implanted in the skull, over the area of the tumor. When activated, sound waves cause microbubbles to vibrate, temporarily opening the blood-brain barrier. This permits more of the chemo drug to reach the tumor. The device is activated before each round of chemotherapy, Sottilini told HealthDay. Two minutes of low-intensity ultrasound is enough to open the for about six hours and increase the concentration of medication five to seven times, he said.

The researchers used the chemo drug carboplatin for the study. The experimental treatments were conducted monthly for six months at most or until evidence of tumor progression was detected. According to Sottilini, the device appeared safe to use in areas of the brain that control speech, movement, and other senses. This phase 1 trial was not designed to test whether the higher doses of chemotherapy that passed into the brain were effective. However, tumor growth did not progress in nine patients, the researchers said.

The research was partially funded by CarThera.


Explore further

Blood-brain barrier opened noninvasively with focused ultrasound for the first time

More information: A. Carpentier et al. Clinical trial of blood-brain barrier disruption by pulsed ultrasound, Science Translational Medicine (2016). DOI: 10.1126/scitranslmed.aaf6086
Journal information: Science Translational Medicine

Copyright © 2016 HealthDay. All rights reserved.

Citation: Implantable ultrasound device augments chemo in glioblastoma (2016, June 16) retrieved 25 May 2019 from https://medicalxpress.com/news/2016-06-implantable-ultrasound-device-augments-chemo.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
114 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more